No Data
No Data
No Data
No Data
No Data
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Friday, the FDA approved Pfizer Inc's (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate to severe hemophilia B in adult patients who currently use factor IX (FIX) prophylaxis therapy or h
Benzinga11minutes ago
19 Out 20 S&P 500 Healthcare Companies Beat Profit Estimates - Earnings Scorecard
Seeking Alpha12:56 ET
Pfizer (NYSE:PFE) Notches Up on New FDA Approval
TipRanks12:33 ET
Options Corner: Pfizer's Options Market Sees Big Money Take Bullish Stance
Deep-pocketed investors have adopted a bullish approach towards Pfizer (NYSE:PFE), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this
BenzingaApr 26 10:22 ET
Pfizer Gains as Gene Therapy Wins FDA Nod
Baystreet.caApr 26 10:03 ET
Pfizer Receives FDA Approval for Bleeding Disorder Treatment -- Barrons.com
By Emily Dattilo Pfizer has received approval from the Food and Drug Administration for a rare genetic bleeding disorder treatment -- the drug-maker's first gene therapy to be approved in the U.S. T
Barron'sApr 26 09:35 ET
多買多賺買少少虧金牛 : Haha the first thing comes to my mind the same puzzle
MooMamaLlama : I bet they're eyeing it... pfe and gsk would be the main ones with the $ to back an offer...anyone else?
Calvin Hobbs 1014117OP : This stock will go back to 45 I think
70133785 Calvin Hobbs 1014117OP: 那要等四五年了吧
103430043 : Maybe rise to $35 in less than one year
小超人爸爸 : Whats the logic behind?
70133785 : 又套了不少马!套马杆的作用就是起伏跌宕中套
Jorge DomesticOP : diamond balls
FANCY PANTS : What were the stats before covid shots?
Jorge DomesticOP : what you mean? I've joined FB I ain't sell anything yet. in waiting for everything to soar before I sell
Calvin Hobbs 1014117 : Free advertising
No Data
No Data